{"title":"经颅磁刺激治疗重度抑郁症:临床、经济和实际问题第二部分","authors":"M. Demitrack","doi":"10.1097/01.IDT.0000384050.93852.3e","DOIUrl":null,"url":null,"abstract":"clinical and economic burden of major depression; the compounding issue of treatment resistance; and cost analyses comparing transcranial magnetic stimulation (TMS) with standard clinical care (e.g., complex pharmacotherapy, electrconvulsive therapy [ECT]) for treatmentresistant depression (TRD). Part II reviews practical issues in the clinical use of TMS, which have emerged since its approval by the FDA for this indication.","PeriodicalId":90307,"journal":{"name":"Psychopharm review : timely reports in psychopharmacology and device-based therapies","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2010-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/01.IDT.0000384050.93852.3e","citationCount":"0","resultStr":"{\"title\":\"Transcranial Magnetic Stimulation for the Treatment of Major Depression: Clinical, Economic, and Practical Issues Part II\",\"authors\":\"M. Demitrack\",\"doi\":\"10.1097/01.IDT.0000384050.93852.3e\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"clinical and economic burden of major depression; the compounding issue of treatment resistance; and cost analyses comparing transcranial magnetic stimulation (TMS) with standard clinical care (e.g., complex pharmacotherapy, electrconvulsive therapy [ECT]) for treatmentresistant depression (TRD). Part II reviews practical issues in the clinical use of TMS, which have emerged since its approval by the FDA for this indication.\",\"PeriodicalId\":90307,\"journal\":{\"name\":\"Psychopharm review : timely reports in psychopharmacology and device-based therapies\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2010-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1097/01.IDT.0000384050.93852.3e\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Psychopharm review : timely reports in psychopharmacology and device-based therapies\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/01.IDT.0000384050.93852.3e\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychopharm review : timely reports in psychopharmacology and device-based therapies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/01.IDT.0000384050.93852.3e","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Transcranial Magnetic Stimulation for the Treatment of Major Depression: Clinical, Economic, and Practical Issues Part II
clinical and economic burden of major depression; the compounding issue of treatment resistance; and cost analyses comparing transcranial magnetic stimulation (TMS) with standard clinical care (e.g., complex pharmacotherapy, electrconvulsive therapy [ECT]) for treatmentresistant depression (TRD). Part II reviews practical issues in the clinical use of TMS, which have emerged since its approval by the FDA for this indication.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
